Atara Biotherapeutics
ATRA
ATRA
125 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 29 reducing their positions, and 10 closing their positions.
Holders
125
Holders Change
+9
Holders Change %
+7.76%
% of All Funds
2.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
19
Increased
62
Reduced
29
Closed
10
Calls
$14.4M
Puts
$12M
Net Calls
+$2.39M
Net Calls Change
-$24.2M
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$32.6M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$87.5M |
3 |
3
BlackRock
New York
|
$124M |
4 |
4
Wells Fargo
San Francisco,
California
|
$14.2M |
5 |
5
Goldman Sachs
New York
|
$15.5M |